Etana Biotechnologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Youth on Tech | Preventing the Next Pandemic

/PRNewswire/ Youth on Tech is a brand-new program produced by Science and Technology Daily. In this program, we invite young scientists from around the.

Susan buenoQi yingzhouChristian karol saputraTsinghua universityTechnology dailyWorld health organizationImmunization weekLei yuqingEtana biotechnologiesPontificia universidad catScience and technology daily

Indonesia grants emergency use nod to Walvax Biotechnology mRNA COVID vaccine AWcorna

Jakarta: Indonesia said it has granted emergency use approval to an mRNA COVID-19 vaccine developed by a Chinese company, becoming the first country, ahead of even China, to do so.Indonesia s food and.

Jakarta rayaDicky budimanAbogen biosciencesAustralia griffith universityWalvax biotechnologyGriffith universitySuzhou abogen biosciencesSuzhou abogenCovid 19Coronavirus vaccinePenny lukitoEtana biotechnologies

Kintor Pharma Collaborates with Etana to Commercialize Proxalutamide for Treatment of COVID-19 in Indonesia

Kintor Pharma Collaborates with Etana to Commercialize Proxalutamide for Treatment of COVID-19 in Indonesia
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesKintor pharmaNathan tirtanaKintor pharmaceuticalsEuropean unionPrnewswire kintor pharmaceutical limited pharmaKintor pharmaceuticalPharmaceutical limitedBiotechnologies indonesiaLicensing agreementYouzhi tongSouth americaEtana biotechnologiesSoutheast asian

Kintor Pharma Collaborates with Etana to Commercialize Proxalutamide for Treatment of COVID-19 in Indonesia

Innovent Announces an Out-license Agreement with PT Etana Biotechnologies Indonesia to Launch BYVASDA® (Bevacizumab Biosimilar) in Indonesia

Press release content from PR Newswire. The AP news staff was not involved in its creation. Innovent Announces an Out-license Agreement with PT Etana Biotechnologies Indonesia to Launch BYVASDA® (Bevacizumab Biosimilar) in Indonesia January 19, 2021 GMT SAN FRANCISCO and SUZHOU, China, Jan. 18, 2021 /PRNewswire/ Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced an agreement with PT Etana Biotechnologies Indonesia (Etana) to out-license BYVASDA® (Bevacizumab Biosimilar)’s development and commercialization rights in Indonesia to Etana. Etana is committed to launch BYVASDA® in the local market. In return, Innovent will receive milestones for development and commercialization as well as double-digit royalties on net sales. The specific financial terms were not disclosed.

United statesHong kongAdimab incyteNathan tirtanaEli lillyBevacizumab biosimilarPrnewswire innovent biologics incCoherus biosciences incMd anderson cancer centerBusiness development of innoventNational reimbursement drug listInnovent biologics incBiotechnologies indonesiaCoherus biosciencesNorth americaSoutheast asian